I Keep Buying Oracle Because It Will Become a Tier-1 Hyperscaler

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • Oracle's $638 billion RPO, up 363% year-over-year, reflects customers paying upfront to fund AI infrastructure with returns in the high 20s.

  • ORCL trades at a forward P/E of 19 and PEG of 0.851, offering cheaper growth exposure than MSFT despite accelerating 93% IaaS revenue growth.

  • The most widely read finance newsletter on Substack isn't published by a bank, it's Doomberg, where 383,000+ readers get the energy and macro analysis the mainstream press misses. 24/7 Wall St. readers save 17% on their first year here.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

I keep hitting the buy button on Oracle (NYSE:ORCL | ORCL Price Prediction) because I think the market is still pricing it as a legacy database company while it quietly builds itself into a Tier-1 hyperscaler. I only need it to keep doing what it is already doing: acting as the high-performance engine for AI compute and the enterprise data backend that runs inside every rival cloud. If it executes the physical data center buildout and converts its backlog into operational cash flow, Tier-1 inclusion is only a matter of time.

The Backlog Tells the Story

Start with Remaining Performance Obligations. Oracle closed Q4 FY2026 with $638 billion in RPO, up 363% year over year. That is contracted, committed revenue. Four customers each signed for more than $8 billion in Q4 alone, and Oracle inked $67 billion in AI infrastructure contracts in the quarter. Of that pipeline, $75 billion is structured as bring-your-own-hardware or customer-prepaid, which shifts capital risk off Oracle’s balance sheet while preserving margin. CFO Hilary Maxson told the call the return on invested capital on that model sits in the high 20s at steady state. That is infrastructure economics I can underwrite.

Cloud Growth Is Accelerating

Cloud infrastructure revenue accelerated every quarter of FY2026: 55%, 68%, 84%, and 93%. Total cloud revenue in Q4 hit $9.913 billion, 52% of total sales. Multicloud AI database, which lets Oracle databases run inside AWS, Google Cloud, and Azure, grew 404% in Q4. Global GPU utilization sits at 97.5%. Management guided FY2027 revenue to $90 billion with non-GAAP EPS of $8.05, and Safra Catz laid out an OCI ramp reaching $144 billion in five years, most of it already booked.

Why Oracle Over the Obvious Names

The reflex trade is Microsoft (NASDAQ:MSFT) for cloud plus AI. I own it and I am not selling it. But my incremental dollars go to Oracle because the acceleration is here. IaaS growth at 93% off a smaller base with an RPO backlog up 363% is the kind of setup you get once in a franchise. Oracle also trades at a forward P/E of 19 against a PEG of 0.851. That is a growth rate the multiple has not caught up to. The consensus analyst target of $246.43 versus the current $150.52 reflects the same disconnect I see.

The Risk I Own

Free cash flow was negative $23.686 billion in FY2026. Capex ran $55.663 billion and FY2027 net cash capex is guided near $70 billion, funded partly by ~$40 billion in debt and equity including a $20 billion at-the-market equity issuance. If GPU demand cools or a big customer defers, the balance sheet gets tested. What holds the thesis is that operating cash flow already grew 54% to $31.977 billion, and the prepaid contract structure means customers are funding the buildout in front of the depreciation curve.

Why the Buy Button Stays Active

Oracle is being paid, in cash, up front, to build the physical layer of the AI era, and it is doing so with contracts that carry ROIC in the high 20s. Every quarter the cloud share of revenue climbs and the backlog thickens. I keep buying because the market keeps mistaking a hyperscaler in the making for a bond proxy with a 1.28% dividend yield, and I would rather own the mistake than argue with it.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

WDC Vol: 1,688,841
AMAT Vol: 1,641,901
MU Vol: 6,975,490
TER Vol: 249,377
GLW Vol: 1,026,908

Top Losing Stocks

CTRA Vol: 73,319,495
STZ Vol: 186,626
TAP Vol: 256,038
SMCI Vol: 12,000,593
BLDR Vol: 91,072